Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
53.5M
-
Shares change
-
+5.83M
-
Total reported value, excl. options
-
$475M
-
Value change
-
+$43.2M
-
Put/Call ratio
-
0.75
-
Number of buys
-
105
-
Number of sells
-
-107
-
Price
-
$8.87
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2022
305 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2022.
Editas Medicine, Inc. - Common Stock (EDIT) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.5M shares
of 82.8M outstanding shares and own 64.69% of the company stock.
Largest 10 shareholders include STATE STREET CORP (9.22M shares), BlackRock Inc. (7.34M shares), VANGUARD GROUP INC (6.87M shares), MILLENNIUM MANAGEMENT LLC (2.14M shares), Woodline Partners LP (2.08M shares), DIMENSIONAL FUND ADVISORS LP (1.65M shares), PFM Health Sciences, LP (1.47M shares), GEODE CAPITAL MANAGEMENT, LLC (1.38M shares), JPMORGAN CHASE & CO (1.18M shares), and Capital World Investors (1.1M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.